Clear Harbor Asset Management’s Arbutus Biopharma ABUS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$122K	Sell	27,000 -47,761	-64%	-$209K	0.01%	430
2025 Q4	$360K	Hold	74,761	–	–	0.02%	340
2025 Q3	$339K	Sell	74,761 -5,000	-6%	-$18.4K	0.02%	339
2025 Q2	$246K	Hold	79,761	–	–	0.02%	361
2025 Q1	$278K	Hold	79,761	–	–	0.02%	333
2024 Q4	$261K	Buy	79,761 +5,000	+7%	+$18.4K	0.02%	328
2024 Q3	$288K	Sell	74,761 -26,000	-26%	-$99.7K	0.02%	300
2024 Q2	$311K	Sell	100,761 -15,500	-13%	-$46.5K	0.03%	287
2024 Q1	$300K	Sell	116,261 -23,000	-17%	-$59.6K	0.03%	289
2023 Q4	$348K	Buy	139,261 +7,500	+6%	+$14.7K	0.03%	267
2023 Q3	$267K	Buy	131,761 +78,761	+149%	+$165K	0.03%	280
2023 Q2	$122K	Hold	53,000	–	–	0.01%	331
2023 Q1	$161K	Hold	53,000	–	–	0.02%	348
2022 Q4	$123K	Buy	+53,000	New	+$127K	0.02%	337